Free Trial

Cytosorbents (CTSO) Competitors

Cytosorbents logo
$0.91 -0.01 (-1.15%)
Closing price 10/16/2025 04:00 PM Eastern
Extended Trading
$0.90 0.00 (-0.06%)
As of 10/16/2025 07:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CTSO vs. INGN, TLSI, CVRX, NNOX, CV, INFU, SKIN, ELMD, BSGM, and STIM

Should you be buying Cytosorbents stock or one of its competitors? The main competitors of Cytosorbents include Inogen (INGN), TriSalus Life Sciences (TLSI), CVRx (CVRX), Nano-X Imaging (NNOX), CapsoVision (CV), InfuSystem (INFU), Beauty Health (SKIN), Electromed (ELMD), Biosig Technologies (BSGM), and Neuronetics (STIM). These companies are all part of the "medical equipment" industry.

Cytosorbents vs. Its Competitors

Inogen (NASDAQ:INGN) and Cytosorbents (NASDAQ:CTSO) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, media sentiment, analyst recommendations, institutional ownership, risk, valuation and dividends.

Inogen has a net margin of -7.58% compared to Cytosorbents' net margin of -25.58%. Inogen's return on equity of -13.77% beat Cytosorbents' return on equity.

Company Net Margins Return on Equity Return on Assets
Inogen-7.58% -13.77% -8.52%
Cytosorbents -25.58%-111.97%-29.00%

Cytosorbents has lower revenue, but higher earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than Cytosorbents, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inogen$335.70M0.69-$35.89M-$1.06-8.03
Cytosorbents$35.60M1.60-$20.72M-$0.17-5.33

In the previous week, Inogen had 2 more articles in the media than Cytosorbents. MarketBeat recorded 4 mentions for Inogen and 2 mentions for Cytosorbents. Cytosorbents' average media sentiment score of 0.83 beat Inogen's score of 0.77 indicating that Cytosorbents is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inogen
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cytosorbents
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

89.9% of Inogen shares are held by institutional investors. Comparatively, 32.9% of Cytosorbents shares are held by institutional investors. 1.5% of Inogen shares are held by insiders. Comparatively, 7.3% of Cytosorbents shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Inogen has a beta of 1.8, indicating that its share price is 80% more volatile than the S&P 500. Comparatively, Cytosorbents has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500.

Inogen currently has a consensus price target of $11.00, indicating a potential upside of 29.26%. Cytosorbents has a consensus price target of $5.50, indicating a potential upside of 507.40%. Given Cytosorbents' higher probable upside, analysts plainly believe Cytosorbents is more favorable than Inogen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inogen
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Cytosorbents
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Inogen and Cytosorbents tied by winning 7 of the 14 factors compared between the two stocks.

Get Cytosorbents News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CTSO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CTSO vs. The Competition

MetricCytosorbentsMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$57.49M$10.66B$6.08B$10.55B
Dividend YieldN/A1.91%5.73%4.78%
P/E Ratio-5.3319.6984.6127.19
Price / Sales1.6026.86597.35132.96
Price / CashN/A25.4537.8662.13
Price / Book4.533.4212.456.65
Net Income-$20.72M$208.83M$3.32B$276.79M
7 Day Performance-1.12%1.31%2.27%1.75%
1 Month Performance0.14%1.60%9.64%5.15%
1 Year Performance-19.87%-7.78%74.87%36.96%

Cytosorbents Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CTSO
Cytosorbents
1.9035 of 5 stars
$0.91
-1.1%
$5.50
+507.4%
-19.2%$57.49M$35.60M-5.33220Analyst Forecast
INGN
Inogen
3.8714 of 5 stars
$8.43
-2.5%
$11.00
+30.5%
-9.3%$233.90M$335.70M-7.951,030Analyst Forecast
TLSI
TriSalus Life Sciences
2.2955 of 5 stars
$4.63
+0.2%
$10.90
+135.4%
+5.8%$230.39M$29.43M-3.92106Short Interest ↑
CVRX
CVRx
2.6238 of 5 stars
$8.73
+0.2%
$14.00
+60.4%
+13.8%$227.78M$51.29M-4.16160Positive News
NNOX
Nano-X Imaging
2.5172 of 5 stars
$4.13
+5.1%
$8.50
+105.8%
-31.3%$227.07M$11.28M-4.59190Positive News
CV
CapsoVision
N/A$4.57
-4.6%
$5.50
+20.4%
N/A$224.05MN/A0.0090Short Interest ↑
INFU
InfuSystem
4.0675 of 5 stars
$10.50
+1.4%
$13.50
+28.6%
+31.6%$214.47M$139.89M175.03410Positive News
Short Interest ↑
SKIN
Beauty Health
2.1364 of 5 stars
$1.67
-0.6%
$2.81
+68.4%
-11.7%$213.07M$334.30M-5.961,030
ELMD
Electromed
3.3882 of 5 stars
$24.77
-1.2%
$36.25
+46.3%
+5.4%$207.47M$64M33.03160
BSGM
Biosig Technologies
1.6444 of 5 stars
$6.35
+42.6%
$10.00
+57.6%
+1,852.3%$199.35M$13K0.0050Gap Down
High Trading Volume
STIM
Neuronetics
2.2517 of 5 stars
$2.83
-0.7%
$7.00
+147.3%
+214.4%$188.46M$74.89M-2.50180

Related Companies and Tools


This page (NASDAQ:CTSO) was last updated on 10/17/2025 by MarketBeat.com Staff
From Our Partners